Use of ep4 receptor agonists for treating neuropathic pain

摘要

The present invention relates to the use of an EP4 receptor agonist and pharmaceutically acceptable derivatives thereof for the manufacture of a medicament for the treatment of neurpathic pain, excluding use of [4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetic acid and pharmaceutically acceptable derivatives thereof.